Shapiro MD - Search Results

1

Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk.

Rikhi R, Shapiro MD. Rikhi R, et al. Among authors: shapiro md. J Clin Med. 2022 Aug 8;11(15):4611. doi: 10.3390/jcm11154611. J Clin Med. 2022. PMID: 35956226 Free PMC article. Review.

2

The Evolving Understanding and Approach to Residual Cardiovascular Risk Management.

Dhindsa DS, Sandesara PB, Shapiro MD, Wong ND. Dhindsa DS, et al. Among authors: shapiro md. Front Cardiovasc Med. 2020 May 13;7:88. doi: 10.3389/fcvm.2020.00088. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32478100 Free PMC article. Review.

3

Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).

Rikhi R, Hammoud A, Ashburn N, Snavely AC, Michos ED, Chevli P, Tsai MY, Herrington D, Shapiro MD. Rikhi R, et al. Among authors: shapiro md. Atherosclerosis. 2022 Dec;363:102-108. doi: 10.1016/j.atherosclerosis.2022.10.004. Epub 2022 Oct 8. Atherosclerosis. 2022. PMID: 36253168 Free PMC article.

4

Association of Lp(a) (Lipoprotein[a]) and Hypertension in Primary Prevention of Cardiovascular Disease: The MESA.

Rikhi R, Bhatia HS, Schaich CL, Ashburn N, Tsai MY, Michos ED, Chevli PA, Herrington DM, Tsimikas S, Shapiro MD. Rikhi R, et al. Among authors: shapiro md. Hypertension. 2023 Feb;80(2):352-360. doi: 10.1161/HYPERTENSIONAHA.122.20189. Epub 2022 Dec 13. Hypertension. 2023. PMID: 36511156 Free PMC article.

5

Relationship Between Sarcopenia and Intensive Blood Pressure Control Efficacy and Safety: A Secondary Analysis of SPRINT.

Mirzai S, Persits I, Kazibwe R, Gabani M, Seals A, Singleton MJ, Rikhi R, Chevli PA, Carbone S, Tang WHW, Yeboah J, Williamson JD, Kitzman DW, Herrington DM, Shapiro MD. Mirzai S, et al. Among authors: shapiro md. Hypertension. 2024 Aug;81(8):e77-e87. doi: 10.1161/HYPERTENSIONAHA.124.23011. Epub 2024 Jun 17. Hypertension. 2024. PMID: 38881460 Clinical Trial.

6

Impact of Statin Therapy on Diabetes Incidence: Implications for Primary Prevention.

Rikhi R, Shapiro MD. Rikhi R, et al. Among authors: shapiro md. Curr Cardiol Rep. 2024 Dec;26(12):1447-1452. doi: 10.1007/s11886-024-02141-3. Epub 2024 Sep 20. Curr Cardiol Rep. 2024. PMID: 39302589 Free PMC article. Review.

7

Interpreting the Findings From the Recent PCSK9 Monoclonal Antibody Cardiovascular Outcomes Trials.

Wong ND, Shapiro MD. Wong ND, et al. Among authors: shapiro md. Front Cardiovasc Med. 2019 Mar 6;6:14. doi: 10.3389/fcvm.2019.00014. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 30895178 Free PMC article. Review.

8

Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9.

German CA, Shapiro MD. German CA, et al. Among authors: shapiro md. BioDrugs. 2020 Feb;34(1):1-9. doi: 10.1007/s40259-019-00399-6. BioDrugs. 2020. PMID: 31782112 Review.

9

"Cholesterol-Years" for ASCVD Risk Prediction and Treatment.

Shapiro MD, Bhatt DL. Shapiro MD, et al. J Am Coll Cardiol. 2020 Sep 29;76(13):1517-1520. doi: 10.1016/j.jacc.2020.08.004. J Am Coll Cardiol. 2020. PMID: 32972527 Free article. No abstract available.

10

Preventing Diabetes and Atherosclerosis in the Cardiometabolic Syndrome.

Ahmad MI, Shapiro MD. Ahmad MI, et al. Among authors: shapiro md. Curr Atheroscler Rep. 2021 Mar 9;23(4):16. doi: 10.1007/s11883-021-00913-8. Curr Atheroscler Rep. 2021. PMID: 33686460 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters